Papillomaviruses are a group of small, nonenveloped, double-stranded DNA viruses that are epitheliotropic. An approximately 8,000-nucleotide circular genome of these viruses encodes 7 to 9 open reading frames, depending on the genotype. Papillomaviruses express 3 regulatory proteins (E1, E2, and E4), 3 oncogenic proteins (E5, E6, and E7), and 2 viral capsid proteins (L1 and L2). The L1 protein is highly conserved, and papillomavirus classification is generally based on sequence analysis of the amino acids of this major capsid protein.1
These epitheliotropic viruses infect a wide range of birds and mammals, including humans,2 and cause benign cutaneous and mucosal epithelial proliferations called papillomas (warts). Occasionally, some papillomaviruses can cause malignant epithelial lesions (carcinomas). Environmental factors, host genetic factors, or both may play a role in the progression of papillomavirus-associated malignancy3,4
Typically, papillomaviruses are host and tissue specific, but there are some exceptions. Equine and feline sarcoids have been associated with bovine papillomavirus.5,6 In 2 recent studies7,8 in cats, HPV type 9 DNA was extracted from a cutaneous papilloma, and the DNA from a papillomavirus present in an SCC of the oral cavity had 92% nucleotide sequence similarity with HPV type 76 DNA. However, those investigators analyzed approximately 25%7 and 30%8 of the L1 gene; thus, the extent to which the HPVs could be genotyped was somewhat limited. Nonetheless, the host species fidelity of papillomaviruses appears not to be absolute, especially in humans and felids. The purpose of the study reported here was to characterize the L1 gene of papillomaviruses detected in epithelial lesions of cats and to determine the relationship between those L1 gene nucleotide sequences and known L1 gene nucleotide sequences of human and feline papillomaviruses.
Materials and Methods
Samples and extraction of viral DNA—Ten tissue samples from 8 cats undergoing a biopsy procedure submitted for histopathologic examination to a pathology servicea from 1999 through 2007 were used in this study. A commercially available kitb was used to extract viral DNA from these samples according to the protocol suggested by the manufacturer, and the DNA was stored at −20°C prior to analysis.
DNA amplification—For sequence analysis and virus classification, primers were designed to amplify the L1 gene of papillomaviruses (Appendix). Each PCR mixture contained 1 μL each of a forward and reverse primer (concentration, 50μM), 8 μL of nuclease-free water, 12.5 μL of a Taq premix,c and 2.5 μL of DNA template. The PCR reactions were conducted in an automated thermocyclerd with the following temperature cycle conditions: 5 cycles of 1 minute at 95°C, 1.5 minutes at 50°C, and 2 minutes at 72°C and then followed by 35 cycles of 1 minute at 95°C, 1 minute at 55°C, and 2 minutes at 72°C. The PCR products were analyzed by electrophoresis in a 1.4% agarose gel containing ethidium bromide.
Nucleotide sequence alignment and phylogenetic tree analysis—For sequencing of the PCR products, single-stranded DNA was enzymatically digested with a kite according to the manufacturer's instructions or appropriately sized bands were excised from agarose gels and the DNA purified by use of a gel extraction kit.b Digested and purified samples were sequenced at a molecular biology facilityf by use of a sequencing reaction kitg and a capillary electrophoresis DNA analyzer.h Nucleotide sequence results were compared with L1 gene nucleotide sequences reported in GenBank by use of a bioinformatic search tool.i Alignment of gene nucleotide sequences and construction of a phylogenetic tree were performed by use of a commercially available software program.j A gene nucleotide sequence of an amplicon that had < 90% homology with known L1 gene nucleotide sequences was considered a new papillomavirus. Any new papillomaviruses identified in the study were to be submitted for inclusion in the Gen-Bank database.
Results
Of the 10 tissue samples, 9 (designated as samples 18, 37, 38, 52, 61, 132, 134, 138, and 162) were collected from the skin and 1 (designated as sample 160) was collected from a lesion of the oral mucosa overlying the mandible. In the 9 skin samples, 5 (samples 18, 61, 132, 134, and 138), 3 (samples 37, 38, and 52), and 1 (sample 162) of the lesions were diagnosed as SCC, SCC in situ (ie, tumor did not penetrate the epidermal basement membrane), and dysplasia, respectively. In the tissue sample obtained from the mandible, the lesion was diagnosed as an oral SCC. Amplicons of the L1 gene were successfully made from all 10 tissue samples. Nucleotide sequences of amplicons were compared with known sequences of papillomaviruses.
Sequence alignment of the L1 gene of 7 amplicons (samples 18, 37, 38, 52, 61, 132, and 134 derived from 3 SCCs in situ and 4 SCCs) had 98% to 100% nucleotide sequence homology with the L1 gene nucleotide sequence of the reported FdPV2 gene nucleotide sequence (GenBank accession No. EU796884); however, 27 nucleotides from the 5′ end of the amplicon were not amplified in 3 (samples 38, 52, and 61) of these 7 amplicons. Phylogenetic tree analysis based on nucleotide sequence alignment (ie, nucleotides 6,205 through 7,692) of the L1 gene of these 7 amplicons and the L1 gene of FPV genomes (FdPV1 [GenBank accession No. AF480454], FdPV2 [GenBank accession No. EU796884], Panthera leo persica papillomavirus type 1 [GenBank accession No. AY904724], Lynx rufus papillomavirus type 1 [GenBank accession No. AY904722], Puma concolor papillomavirus type 1 [GenBank accession No. AY904723], and Uncia uncia papillomavirus type 1 [GenBank accession No. DQ180494]) revealed that these papillomaviruses were grouped into a single clade with the reported FdPV2 L1 gene nucleotide sequence (GenBank accession No. EU796884; Figure 1).

Results of phylogenetic tree analysis that was based on sequence alignment (ie, nucleotides 6,205 through 7,692) of L1 gene nucleotide sequences of 7 amplicons derived from papillomaviruses in 3 SCCs in situ and 4 SCCs in skin samples (samples 18, 37, 38, 52, 61, 132, and 134 [obtained from a group of 8 cats]) with the L1 gene nucleotide sequences of FPV genomes (FdPV1 [GenBank accession No. AF480454], FdPV2 [GenBank accession No. EU796884], Panthera leo persica papillomavirus type 1 [GenBank accession No. AY904724], Lynx rufus papillomavirus type 1 [GenBank accession No. AY904722], Puma concolor papillomavirus type 1 [GenBank accession No. AY904723], and Uncia uncia papillomavirus type 1 [GenBank accession No. DQ180494]). These 7 papillomaviruses were grouped into 1 clade with the reported L1 gene nucleotide sequence of FdPV2. LrPV1 = Lynx rufus papillomavirus type 1. PcPV1 = Puma concolor papillomavirus type 1. PlpPV1 = Panthera leo persica papillomavirus type 1. UuPV1 = Uncia uncia papillomavirus type 1.
Citation: American Journal of Veterinary Research 71, 12; 10.2460/ajvr.71.12.1457

Results of phylogenetic tree analysis that was based on sequence alignment (ie, nucleotides 6,205 through 7,692) of L1 gene nucleotide sequences of 7 amplicons derived from papillomaviruses in 3 SCCs in situ and 4 SCCs in skin samples (samples 18, 37, 38, 52, 61, 132, and 134 [obtained from a group of 8 cats]) with the L1 gene nucleotide sequences of FPV genomes (FdPV1 [GenBank accession No. AF480454], FdPV2 [GenBank accession No. EU796884], Panthera leo persica papillomavirus type 1 [GenBank accession No. AY904724], Lynx rufus papillomavirus type 1 [GenBank accession No. AY904722], Puma concolor papillomavirus type 1 [GenBank accession No. AY904723], and Uncia uncia papillomavirus type 1 [GenBank accession No. DQ180494]). These 7 papillomaviruses were grouped into 1 clade with the reported L1 gene nucleotide sequence of FdPV2. LrPV1 = Lynx rufus papillomavirus type 1. PcPV1 = Puma concolor papillomavirus type 1. PlpPV1 = Panthera leo persica papillomavirus type 1. UuPV1 = Uncia uncia papillomavirus type 1.
Citation: American Journal of Veterinary Research 71, 12; 10.2460/ajvr.71.12.1457
Results of phylogenetic tree analysis that was based on sequence alignment (ie, nucleotides 6,205 through 7,692) of L1 gene nucleotide sequences of 7 amplicons derived from papillomaviruses in 3 SCCs in situ and 4 SCCs in skin samples (samples 18, 37, 38, 52, 61, 132, and 134 [obtained from a group of 8 cats]) with the L1 gene nucleotide sequences of FPV genomes (FdPV1 [GenBank accession No. AF480454], FdPV2 [GenBank accession No. EU796884], Panthera leo persica papillomavirus type 1 [GenBank accession No. AY904724], Lynx rufus papillomavirus type 1 [GenBank accession No. AY904722], Puma concolor papillomavirus type 1 [GenBank accession No. AY904723], and Uncia uncia papillomavirus type 1 [GenBank accession No. DQ180494]). These 7 papillomaviruses were grouped into 1 clade with the reported L1 gene nucleotide sequence of FdPV2. LrPV1 = Lynx rufus papillomavirus type 1. PcPV1 = Puma concolor papillomavirus type 1. PlpPV1 = Panthera leo persica papillomavirus type 1. UuPV1 = Uncia uncia papillomavirus type 1.
Citation: American Journal of Veterinary Research 71, 12; 10.2460/ajvr.71.12.1457
Sequence alignment of the nucleotide and deduced amino acid sequences of the amplicons derived from 2 samples, which were an oral SCC (sample 160) and a cutaneous dysplasia (sample 162), had 99% nucleotide sequence homology (ie, nucleotides 5,260 to 7,174) with the L1 gene nucleotide sequence of HPV type 38b subtype FA125. Alignment of the L1 gene nucleotide sequence derived from sample 138 (the remaining skin-associated SCC) had 84% nucleotide sequence homology (ie, nucleotides 5,260 through 7,105) with the L1 gene nucleotide sequence of HPV type 80, and the nucleotide sequence was submitted for inclusion in the GenBank database (accession No. GQ916646) as a novel papillomavirus. Phylogenetic tree analysis based on the alignment of 1,850-bp sequences of these 3 amplicons and the most closely aligned L1 gene nucleotide sequences (HPV type 38b subtype FA125 [GenBank accession No. DQ090005], type 38 [GenBank accession No. U31787.1], type 110 [GenBank accession No. EU410348.1], type 15 [GenBank accession No. X74468.1], type37 [GenBank accession No. U31786.1], and type 80 [GenBank accession No. Y15176] and FdPV1 [GenBank accession No. AF480454], FdPV2 [GenBank accession No. EU796884], and CPV type 3 [GenBank accession No. DQ295066]) of papillomaviruses reported in GenBank revealed that sequences of these 3 papillomaviruses were grouped into 2 clades that were not similar to the clades of FdPVl, FdPV2, or CPV (Figure 2).

Results of phylogenetic tree analysis that was based on sequence alignment (ie, nucleotides 5,260 through 7,109) of a 1,850-bp sequence of the L1 gene amplicon derived from papillomaviruses in a cutaneous dysplastic lesion, cutaneous SCC, and SCC of the oral mucosa in feline samples (samples 138, 160, and 162 [each obtained from a different cat]) with L1 gene reference sequences (HPV type 38b subtype FA125 [GenBank accession No. DQ090005], type 38 [GenBank accession No. U31787.1], type 110 [GenBank accession No. EU410348.1], type 15 [GenBank accession No. X74468.1], type 37 [GenBank accession No. U31786.1], and type 80 [GenBank accession No. Y15176] and FdPVl [GenBank accession No. AF480454], FdPV2 [GenBank accession No. EU796884], and CPV type 3 [GenBank accession No. DQ295066]). Gene nucleotide sequences of these papillomaviruses were grouped into 2 clades that were not similar to the clades of FdPVl, FdPV2, or CPV.
Citation: American Journal of Veterinary Research 71, 12; 10.2460/ajvr.71.12.1457

Results of phylogenetic tree analysis that was based on sequence alignment (ie, nucleotides 5,260 through 7,109) of a 1,850-bp sequence of the L1 gene amplicon derived from papillomaviruses in a cutaneous dysplastic lesion, cutaneous SCC, and SCC of the oral mucosa in feline samples (samples 138, 160, and 162 [each obtained from a different cat]) with L1 gene reference sequences (HPV type 38b subtype FA125 [GenBank accession No. DQ090005], type 38 [GenBank accession No. U31787.1], type 110 [GenBank accession No. EU410348.1], type 15 [GenBank accession No. X74468.1], type 37 [GenBank accession No. U31786.1], and type 80 [GenBank accession No. Y15176] and FdPVl [GenBank accession No. AF480454], FdPV2 [GenBank accession No. EU796884], and CPV type 3 [GenBank accession No. DQ295066]). Gene nucleotide sequences of these papillomaviruses were grouped into 2 clades that were not similar to the clades of FdPVl, FdPV2, or CPV.
Citation: American Journal of Veterinary Research 71, 12; 10.2460/ajvr.71.12.1457
Results of phylogenetic tree analysis that was based on sequence alignment (ie, nucleotides 5,260 through 7,109) of a 1,850-bp sequence of the L1 gene amplicon derived from papillomaviruses in a cutaneous dysplastic lesion, cutaneous SCC, and SCC of the oral mucosa in feline samples (samples 138, 160, and 162 [each obtained from a different cat]) with L1 gene reference sequences (HPV type 38b subtype FA125 [GenBank accession No. DQ090005], type 38 [GenBank accession No. U31787.1], type 110 [GenBank accession No. EU410348.1], type 15 [GenBank accession No. X74468.1], type 37 [GenBank accession No. U31786.1], and type 80 [GenBank accession No. Y15176] and FdPVl [GenBank accession No. AF480454], FdPV2 [GenBank accession No. EU796884], and CPV type 3 [GenBank accession No. DQ295066]). Gene nucleotide sequences of these papillomaviruses were grouped into 2 clades that were not similar to the clades of FdPVl, FdPV2, or CPV.
Citation: American Journal of Veterinary Research 71, 12; 10.2460/ajvr.71.12.1457
Discussion
Papillomaviruses have been associated with various diseases of felids, including cutaneous fibropapilloma (eg, sarcoid),6 viral papillomas,9 viral plaques,10 invasive SCC, and bowenoid SCC in situ.10,11 Domestic and nondomestic felids, like many species of mammals and birds, are susceptible to infection with 1 or more types of papillomavirus.12,13
Although papillomaviruses are generally considered to be species specific, the ability of bovine papillomavirus to cross the host-species barrier in horses5 and domestic felids has been reported.6 Investigators of previous studies7,8 of papillomaviruses in cats have examined a portion of the L1 gene. However, papillomavirus classification is usually based on full-length or nearly full-length L1 gene nucleotide sequences. Papilloma viruses are classified into type, subtype, and variant on the basis of the extent to which their highly conserved L1 gene nucleotide sequences differ (ie, sequences differences of ≥ 10%, 2% to 10%, and ≤ 2%, respectively).1
In the study reported here, further nucleotide sequence analysis of the entire L1 gene of the papillomaviruses derived from a cutaneous dysplastic lesion (sample 162) and an oral SCC (sample 160) in samples from cats revealed robust nucleotide sequence homology (ie, 99%) to the L1 gene nucleotide sequence of the β-papillomavirus HPV type 38b subtype FA125. This β-papillomavirus has been associated with skin cancer in humans and is a member of a group of rare HPVs that are heterogeneous and contain subtypes.14 The L1 gene nucleotide sequence derived from another skin-associated SCC (sample 138) in the present study revealed 84% nucleotide sequence homology with the L1 gene nucleotide sequence of HPV type 80. This papillomavirus sequence was submitted to GenBank as a new papillomavirus because the nucleotide sequence identity (homology) of this amplicon was < 90% across almost the entire known L1 genome.
Phylogenetic tree analysis of the 3 aforementioned samples revealed that these sequences were grouped into a clade with HPV and were distinct from the FPV clade. The FPVs FdPVl1 and FdPV215 phylogenetically belong to the λ-papillomavirus genus and a new, as yet unnamed genus, respectively. In contrast, HPVs 38 and 80 are phylogenetically distant from both FdPVl and FdPV2 and are classified within the β-papillomavirus genus.
Among the papillomaviruses detected in cats, most of those that are closely related to HPV (eg, HPV type 9, 38, 76, and 80) belong to the cutaneous β-papillomavirus genus. The genetic organization of β-HPVs differs from that of other HPVs. In humans, the β-HPVs are highly prevalent in the general population and are associated with SCC development.16 In combination with previous reports,7,8 results of the present study have provided supportive evidence of papillomavirus transmission between humans and cats. Cats are often in close contact with humans; thus, the potential for interspecies transmission exists. The mechanism associated with the ability of these viruses to cross the host-species barrier is unknown, but a common viral receptor may exist on both human and feline epithelial cells.
Papillomavirus DNA has been amplified not only from samples of normal (nonlesioned) skin of humans,17 but also from samples of normal (nonlesioned) skin of a cat.18 Because both FPV and HPV can be present in apparently normal skin in humans and cats, it is difficult to determine in which species the virus originated. These findings suggest a potential use of cats in HPV research. Contamination with HPV was unlikely in the present study because all samples were collected and examined in a veterinary laboratory and because no human tissues were examined. Because the present study was restricted to the detection of a single nucleotide sequence of a gene and not an entire genome, detection of the L1 gene nucleotide sequence provides indirect evidence for the presence of papillomavirus.
Seven samples were classified as FdPV2 because amplicons of their L1 gene nucleotide sequence had 98% to 100% homology with the FdPV2 L1 gene nucleotide sequence. Phylogenetic tree analysis of these samples grouped them into 1 clade with FdPV2, whereas other FPVs were grouped into a separate clade. The conserved FdPV2 L1 gene nucleotide sequence has 51.1% nucleotide sequence homology with the L1 gene nucleotide sequence of FdPV1 and has been suggested as a new genus of papillomavirus.15
Papillomaviruses that cause malignancy (ie, high-risk viruses) are different from those that cause benign warts (ie, low-risk viruses).1 Specific types of α-HPV and β-HPV have been detected in cervical and cutaneous cancers, respectively, in humans. Similarly, analysis of the results of the study reported here suggested that FPVs that cause malignant lesions differ from those that cause benign lesions (eg, FdPV1). The FdPV2s detected in the present study were similar to those in previous studies15,18,19 and were amplified from premalignant and malignant lesions. In addition, the detection of the entire FdPV2 L1 gene in cats in the United States in the present study and on different continents11,20 suggests that, in a geographic sense, FdPV2 is distributed widely.
To our knowledge, this is the first study to detect the L1 gene of HPV type 38b subtype FA125 in cats. On the basis of this finding, it appears that papillomaviruses can cross the host-species barrier. In addition, these results provide support for the possibility that other types of HPVs might be detected in cats and the likelihood that a broader association can be made between FdPV2 and malignant lesions of cats.
Abbreviations
CPV | Canine papillomavirus |
FdPV1 | Felis domesticus papillomavirus type 1 |
FdPV2 | Felis domesticus papillomavirus type 2 |
FPV | Feline papillomavirus |
HPV | Human papillomavirus |
SCC | Squamous cell carcinoma |
Department of Pathology, College of Veterinary Medicine, University of Tennessee, Knoxville, Tenn.
QIAquick kit, Qiagen, Valencia, Calif
Ex Taq premix, TakaRa Bio Inc, Otsu, Shiga, Japan.
Eppendorf Mastercycler gradient, Perkin Elmer Inc, Norwalk. Calif.
ExoSAP-IT, USB, Cleveland, Ohio.
Molecular Biology Resource Facility College of Arts and Sciences, University of Tennessee, Knoxville, Tenn.
ABI prism dye terminator cycle sequencing reaction kit, Perkin Elmer Inc, Foster City Calif
ABI 373 DNA, Perkin Elmer Inc, Foster City Calif
BLAST, National Center for Biotechnology Information, National Institutes of Health, Bethesda, Md. Available at: blast.ncbi.nlm.nih.gov/. Accessed Aug 12, 2009.
Lasergene, DNASTAR Inc, Madison, Wis.
References
- 1↑
De Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology 2004; 324:17–27.
- 3
Hall L, Struijk L, Neale RE, et al. Re: Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin (lett). J Natl Cancer Inst 2006; 98:1425–1426.
- 4
McBride P, Neale R, Pandeya N, et al. Sun-related factors, beta-papillomavirus, and actinic keratoses: a prospective study Arch Dermatol 2007; 143:862–868.
- 5↑
Bloch N, Breen M, Spradbrow PBI. Genomic sequences of bovine papillomaviruses in formalin-fixed sarcoids from Australian horses revealed by polymerase chain reaction. Vet Microbiol 1994; 41:163–172.
- 6↑
Teifke JP, Kidney BA, Löhr CV, et al. Detection of papillomavirus-DNA in mesenchymal tumour cells and not in hyperblastic epithelium of feline sarcoids. Vet Dermatol 2003; 14:47–56.
- 7↑
Munday JS, Hanlon EM, Howe L, et al. Feline cutaneous viral papilloma associated with human papillomavirus type 9. Vet Pathol 2007; 44:924–927.
- 8↑
Munday JS, Howe L, French A, et al. Detection of papillomaviral DNA sequences in a feline oral squamous cell carcinoma. Res Vet Sci 2009; 86:359–361.
- 9↑
Carney HC, England JJ, Hodgin EC, et al. Papillomavirus infection of aged Persian cats. J Vet Diagn Invest 1990; 2:294–299.
- 10↑
Wilhelm S, Degorce-Rubiales F, Godson D, et al. Clinical, histological, and immunohistochemical study of feline viral plaques and bowenoid in situ carcinomas. Vet Dermatol 2006; 17:424–431.
- 11
Munday JS, Kiupel M, French AF, et al. Detection of papillomaviral sequences in feline bowenoid in situ carcinoma using consensus primers. Vet Dermatol 2007; 18:241–245.
- 12
Sundberg JP, van Ranst M, Montall R, et al. Feline papillomas and papillomaviruses. Vet Pathol 2000; 37:1–10.
- 13
Sundberg JP, Montali RJ, Bush M, et al. Papillomavirus-associated focal oral hyperplasia in wild and captive Asian lions (Panthera leo persica). J Zoo Wildl Med 1996; 27:61–70.
- 14↑
Hazard K, Eliasson L, Dillner J, et al. Subtype HPV38b[FA125] demonstrates heterogenicity of human papillomavirus type 38. Int J Cancer 2006; 119:11073–11077.
- 15↑
Lange CE, Tobler K, Markau T, et al. Sequence and classification of FdPV2, a papillomavirus isolated from feline bowenoid in situ carcinomas. Vet Microbiol 2009; 137:60–65.
- 16↑
de Koning MNC, Struijk L, Bavinck JNB, et al. Betapapillomaviruses frequently persist in the skin of healthy individuals. J Gen Virol 2007; 88:1489–1495.
- 17↑
Forslund O, Antonsson A, Nordin P, et al. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J Gen Virol 1999; 80:2437–2443.
- 18↑
Munday JS, Willis KA, Kiupel M, et al. Amplification of three different papillomaviral DNA sequences from a cat with viral plaques. Vet Dermatol 2008; 19:400–404.
- 19
Nespeca G, Grest P, Rosenkrantz WS, et al. Detection of novel papillomaviruslike sequences in paraffin-embedded specimens of invasive and in situ squamous carcinomas from cats. Am J Vet Res 2006; 67:2036–2041.
- 20
Munday JS, Kiupel M, French AF, et al. Amplification of papillomaviral DNA sequences from a high proportion of feline cutaneous in situ and invasive squamous cell carcinomas using a nested polymerase chain reaction. Vet Dermatol 2008; 19:259–263.
Appendix
Design of the primers used in the PCR assays for the detection of the L1 gene derived from papillomaviruses in a dysplastic lesion (sample 162 [skin lesion]) and each of 2 SCCs (samples 138 [skin lesion] and 160 [mucosal lesion]) in 3 tissue samples collected from 3 cats (1 sample/cat)
Primer | Oligonucleotide sequence | Amplimer size (nucleotides) | Nucleotide sequence location |
---|---|---|---|
Samples 160 and 162 | |||
HPV1 | |||
Forward | 5′-AGGGTTTGGCAACATAAACAAC-3′ | 492 | 6,269–6,290* |
Reverse | 5′-AG CATCATATTCCTGAG CACCT-3′ | 492 | 6,761–6,740* |
HPV2 | |||
Forward | 5′-AAGGTTCCTTTGACTGCTGAAG-3′ | 465 | 6,828–6,849* |
Reverse | 5′-GGTTGCTGGTGTTGACTTGTT-3′ | 465 | 7,293–7,273* |
HPV4 | |||
Forward | 5′- GGGGACAGCCATTAGGAGTT-3′ | 369 | 5,989–6,008* |
Reverse | 5′-TCTGGATATTTGCAGGTTTCA-3′ | 369 | 6,358–6,338* |
HPV7 | |||
Forward | 5′-TGTCAGATCACAGGATGGTCA-3′ | 345 | 5,816–5,836* |
Reverse | 5′-TTCTCCCAGACAAGGAGTGC-3′ | 345 | 6,161–6,142* |
HPV8 | |||
Forward | 5′-TATCCCGAAAGCAGAGAACG-3′ | 392 | 5,507–5,526* |
Reverse | 5′-CTGGAAAGGTTACCCGGAAT-3′ | 392 | 5,898–5,879* |
HPV10 | |||
Forward | 5′-GGTGCACAAATAGGGTCACA-3′ | 391 | 5,135–5,154* |
Reverse | 5′-CGTTCTCTGCTTTCGGGATA-3′ | 391 | 5,526–5,507* |
Sample 138 | |||
P1 | |||
Forward | 5′-CTTTCCCACAGTTAGTGGTTCTTT-3′ | 320 | 6,605–6,628† |
Reverse | 5′-CCTGAATTCATAGCATTAATTTGTGT-3′ | 320 | 6,925–6,900† |
P6 | |||
Forward | 5′-AATAGDTTTGCWTTAGCAGAT-3′ | 470 | 5,946–5,966† |
Reverse | 5′-CATNGTTARRAAATCTGGATAVTT-3′ | 470 | 6,416–6,399† |
P8 | |||
Forward | 5′-CAAARCACGGAYGADTAYRT-3′ | 310 | 5,778–5,797† |
Reverse | 5′-TCTCTAACTTATTTGAATAGTGGAT-3′ | 310 | 6,088–6,064† |
Nucleotide sequences are based on GenBank accession No. DQ090005 for the HPV type 38b genome.
Nucleotide sequences are based on GenBank accession No. X74468.1 for the HPV type 15 genome.